CIMATRON LIMITED | ||||||||||||||||||||||||||||
RECONCILIATION BETWEEN GAAP AND NON-GAAP INFORMATION | ||||||||||||||||||||||||||||
(US Dollars in thousands, except for per share data) | ||||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
Three months ended |
|
Twelve months ended | ||||||||||||||||||||||||
|
|
December, |
|
December, | ||||||||||||||||||||||||
|
|
|
|
2013 |
|
|
|
|
|
2012 |
|
|
|
|
|
2013 |
|
|
|
|
|
2012 |
|
| ||||
|
|
GAAP |
|
Adj. |
|
NON-GAAP |
|
GAAP |
|
Adj. |
|
NON-GAAP |
|
GAAP |
|
Adj. |
|
NON-GAAP |
|
GAAP |
|
Adj. |
|
NON-GAAP | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Total revenue |
|
12,748 |
|
- |
|
12,748 |
|
12,357 |
|
- |
|
12,357 |
|
44,246 |
|
- |
|
44,246 |
|
42,314 |
|
- |
|
42,314 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Total cost of revenue |
|
1,707 |
|
|
|
1,560 |
|
1,522 |
|
|
|
1,375 |
|
5,829 |
|
|
|
5,241 |
|
5,092 |
|
|
|
4,923 | ||||
|
|
Non-cash amortization of acquired intangible assets |
|
|
|
(147) |
|
|
|
|
|
(147) |
|
|
|
|
|
(588) |
|
|
|
|
|
(588) |
|
| ||
|
|
One-time income from OCS agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
419 |
|
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
Gross profit |
|
11,041 |
|
147 |
|
11,188 |
|
10,835 |
|
147 |
|
10,982 |
|
38,417 |
|
588 |
|
39,005 |
|
37,222 |
|
169 |
|
37,391 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
|
Research and development expenses (1) |
|
2,113 |
|
(12) |
|
2,101 |
|
2,066 |
|
- |
|
2,066 |
|
7,389 |
|
(15) |
|
7,374 |
|
7,001 |
|
- |
|
7,001 | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Selling, general and administrative expenses |
|
6,872 |
|
|
|
6,735 |
|
6,658 |
|
|
|
6,608 |
|
25,566 |
|
|
|
25,314 |
|
24,677 |
|
|
|
24,331 | |||
|
|
Non-cash amortization of acquired intangible assets |
|
|
|
- |
|
|
|
|
|
(50) |
|
|
|
|
|
(85) |
|
|
|
|
|
(346) |
|
| ||
|
|
Stock-based compensation |
|
|
|
(137) |
|
|
|
|
|
- |
|
|
|
|
|
(167) |
|
|
|
|
|
- |
|
| ||
Operating income |
|
2,056 |
|
296 |
|
2,352 |
|
2,111 |
|
197 |
|
2,308 |
|
5,462 |
|
855 |
|
6,317 |
|
5,544 |
|
515 |
|
6,059 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
Financial income (expenses), net |
|
(14) |
|
- |
|
(14) |
|
16 |
|
- |
|
16 |
|
(23) |
|
- |
|
(23) |
|
(35) |
|
- |
|
(35) | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Taxes on income (2) |
|
262 |
|
(867) |
|
(605) |
|
(771) |
|
169 |
|
(602) |
|
(572) |
|
(992) |
|
(1,564) |
|
(1,770) |
|
197 |
|
(1,573) | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Other |
|
(19) |
|
- |
|
(19) |
|
(23) |
|
- |
|
(23) |
|
(15) |
|
- |
|
(15) |
|
(30) |
|
- |
|
(30) | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net income |
|
2,285 |
|
(571) |
|
1,714 |
|
1,333 |
|
366 |
|
1,699 |
|
4,852 |
|
(137) |
|
4,715 |
|
3,709 |
|
712 |
|
4,421 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Less: Net (income) loss attributable to the noncontrolling interest |
|
1 |
|
- |
|
1 |
|
14 |
|
- |
|
14 |
|
(5) |
|
- |
|
(5) |
|
(10) |
|
- |
|
(10) | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Net income attributable to Cimatron's shareholders |
|
$ 2,286 |
|
$ (571) |
|
$ 1,715 |
|
$ 1,347 |
|
$ 366 |
|
$ 1,713 |
|
$ 4,847 |
|
$ (137) |
|
$ 4,710 |
|
$ 3,699 |
|
$ 712 |
|
$ 4,411 | ||||
Net income per share - basic and diluted |
|
$ 0.21 |
|
|
|
$ 0.16 |
|
$ 0.14 |
|
|
|
$ 0.18 |
|
$ 0.49 |
|
|
|
$ 0.48 |
|
$ 0.40 |
|
|
|
$ 0.47 | ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Weighted average number of shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
|
Basic EPS (in thousands) |
|
10,731 |
|
|
|
10,731 |
|
9,338 |
|
|
|
9,338 |
|
9,796 |
|
|
|
9,796 |
|
9,323 |
|
|
|
9,323 | |||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
Diluted EPS (in thousands) |
|
10,855 |
|
|
|
10,855 |
|
9,348 |
|
|
|
9,348 |
|
9,832 |
|
|
|
9,832 |
|
9,337 |
|
|
|
9,337 |